nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.293	0.433	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.229	0.337	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.156	0.23	CbGbCtD
Moxifloxacin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00155	0.244	CbGdCrCtD
Moxifloxacin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000918	0.145	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000579	0.0913	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000579	0.0913	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000579	0.0913	CbGdCrCtD
Moxifloxacin—Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.000546	0.42	CrCbGaD
Moxifloxacin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000398	0.0628	CbGdCrCtD
Moxifloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.000384	0.295	CrCbGaD
Moxifloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.000371	0.285	CrCbGaD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000302	0.0476	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000302	0.0476	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000302	0.0476	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.044	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.044	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.044	CbGdCrCtD
Moxifloxacin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000224	CcSEcCtD
Moxifloxacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000223	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.02e-05	0.000223	CcSEcCtD
Moxifloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.01e-05	0.000223	CcSEcCtD
Moxifloxacin—Fatigue—Etoposide—peripheral nervous system neoplasm	7.01e-05	0.000223	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000223	CcSEcCtD
Moxifloxacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000222	CcSEcCtD
Moxifloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000222	CcSEcCtD
Moxifloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	6.95e-05	0.000221	CcSEcCtD
Moxifloxacin—Pain—Etoposide—peripheral nervous system neoplasm	6.95e-05	0.000221	CcSEcCtD
Moxifloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000221	CcSEcCtD
Moxifloxacin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000221	CcSEcCtD
Moxifloxacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000221	CcSEcCtD
Moxifloxacin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000221	CcSEcCtD
Moxifloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.89e-05	0.000219	CcSEcCtD
Moxifloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.87e-05	0.000218	CcSEcCtD
Moxifloxacin—Sweating—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000218	CcSEcCtD
Moxifloxacin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000218	CcSEcCtD
Moxifloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	6.81e-05	0.000217	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000215	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000215	CcSEcCtD
Moxifloxacin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000215	CcSEcCtD
Moxifloxacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000214	CcSEcCtD
Moxifloxacin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000213	CcSEcCtD
Moxifloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.7e-05	0.000213	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000213	CcSEcCtD
Moxifloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.67e-05	0.000212	CcSEcCtD
Moxifloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000212	CcSEcCtD
Moxifloxacin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000212	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.65e-05	0.000211	CcSEcCtD
Moxifloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	6.64e-05	0.000211	CcSEcCtD
Moxifloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.62e-05	0.000211	CcSEcCtD
Moxifloxacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.00021	CcSEcCtD
Moxifloxacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.00021	CcSEcCtD
Moxifloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	6.57e-05	0.000209	CcSEcCtD
Moxifloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.56e-05	0.000209	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.000209	CcSEcCtD
Moxifloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.54e-05	0.000208	CcSEcCtD
Moxifloxacin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000208	CcSEcCtD
Moxifloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	6.52e-05	0.000208	CcSEcCtD
Moxifloxacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000207	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000206	CcSEcCtD
Moxifloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	6.46e-05	0.000205	CcSEcCtD
Moxifloxacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000205	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000205	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000205	CcSEcCtD
Moxifloxacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000205	CcSEcCtD
Moxifloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.000204	CcSEcCtD
Moxifloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.000204	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000204	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000204	CcSEcCtD
Moxifloxacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000204	CcSEcCtD
Moxifloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000204	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000203	CcSEcCtD
Moxifloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	6.38e-05	0.000203	CcSEcCtD
Moxifloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.37e-05	0.000203	CcSEcCtD
Moxifloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000203	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000202	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000202	CcSEcCtD
Moxifloxacin—Rash—Vincristine—peripheral nervous system neoplasm	6.33e-05	0.000201	CcSEcCtD
Moxifloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.32e-05	0.000201	CcSEcCtD
Moxifloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000201	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000201	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000201	CcSEcCtD
Moxifloxacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.29e-05	0.0002	CcSEcCtD
Moxifloxacin—Headache—Vincristine—peripheral nervous system neoplasm	6.29e-05	0.0002	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000199	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000198	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000197	CcSEcCtD
Moxifloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.19e-05	0.000197	CcSEcCtD
Moxifloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000197	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000196	CcSEcCtD
Moxifloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.07e-05	0.000193	CcSEcCtD
Moxifloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000193	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000192	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000191	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.99e-05	0.000191	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.00019	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.00019	CcSEcCtD
Moxifloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	5.96e-05	0.00019	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000189	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000189	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000189	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000189	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000188	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000187	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000186	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000186	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.000186	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000186	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000185	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000185	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000184	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.000184	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000183	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	5.75e-05	0.000183	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000182	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000182	CcSEcCtD
Moxifloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.64e-05	0.000179	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000179	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000179	CcSEcCtD
Moxifloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	5.6e-05	0.000178	CcSEcCtD
Moxifloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.59e-05	0.000178	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000178	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000178	CcSEcCtD
Moxifloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.56e-05	0.000177	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000176	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000176	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000175	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000175	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000174	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000174	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000173	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000172	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000171	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	5.38e-05	0.000171	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000171	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000171	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.00017	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000169	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000169	CcSEcCtD
Moxifloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	5.27e-05	0.000168	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000167	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000165	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000165	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000164	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000164	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000164	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000164	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000163	CcSEcCtD
Moxifloxacin—Rash—Etoposide—peripheral nervous system neoplasm	5.13e-05	0.000163	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.12e-05	0.000163	CcSEcCtD
Moxifloxacin—Headache—Etoposide—peripheral nervous system neoplasm	5.09e-05	0.000162	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000162	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000161	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000161	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.00016	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.00016	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.00016	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000159	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000159	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000159	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000158	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000157	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000156	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000155	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.000155	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000154	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	4.83e-05	0.000154	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000153	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000152	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000152	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000151	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000151	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000151	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000151	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000151	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.00015	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000149	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000148	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000148	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000148	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000147	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000147	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000146	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000145	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000145	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000145	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000144	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000143	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000143	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000142	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000142	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000142	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000142	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000141	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000141	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.00014	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00014	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00014	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00014	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000139	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000139	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000138	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000138	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000137	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000135	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000135	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000134	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000134	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000132	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000132	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000132	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000131	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000131	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000131	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.00013	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.00013	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.00013	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000129	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000129	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000128	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000128	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000126	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000125	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000125	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000125	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000124	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000124	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000122	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000121	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.00012	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.00012	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000119	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000119	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000119	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000118	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000117	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000116	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000116	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000115	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000115	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000115	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000115	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000115	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000111	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.00011	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000107	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000107	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000106	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000106	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000104	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000103	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.12e-05	9.92e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	9.88e-05	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	9.62e-05	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.01e-05	9.59e-05	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	9.49e-05	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.9e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	9.18e-05	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	2.87e-05	9.14e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.87e-05	9.13e-05	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	2.85e-05	9.08e-05	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	8.87e-05	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.71e-05	8.61e-05	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	8.53e-05	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	8.46e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	8.45e-05	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	8.4e-05	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	7.97e-05	CcSEcCtD
